Fatigue in Rheumatoid Arthritis

Current Rheumatology Reports

Volumn 19, Issue 5, 2017, Pages

  Katz, Patricia ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fatigue; Measurement; Patient reported outcomes; Rheumatoid arthritis

Indexed keywords

COGNITION; COMORBIDITY; DAS28; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; FATIGUE; FUNCTIONAL STATUS; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MUSCLE ATROPHY; MUSCLE WEAKNESS; NONHUMAN; OBESITY; PAIN; PHYSICAL INACTIVITY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SLEEP DISORDER; COMPLICATION; SEVERITY OF ILLNESS INDEX;

ARTHRITIS, RHEUMATOID; FATIGUE; HUMANS; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85017147337     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-017-0649-5     Document Type: Review

References (96)

1. Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, et al. Rheumatology outcomes: the patient’s perspective. J Rheumatol. 2003;30:880–3.
2. Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmen M, et al. Outcomes from the patient perspective workship at OMERACT 8. J Rheumatol. 2003;30:868–72.
3. Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol. 2007;34(5):1174–7.
4. Hewlett S, Chalder T, Choy E, Cramp F, Davis B, Dures E, et al. Fatigue in rheumatoid arthritis: time for a conceptual model. Rheumatology. 2011;50:1004–6.
5. Overman C, Kool M, Da Silva J, Geenen R. The prevalence of severe fatigue in rheumatic disease: an international study. Clin Rheumatol. 2016;35:409–15.
6. •• Nikolaus S, Bode C, Taal E, van de Laar M. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res. 2013;65:1128–46. Systematic review of factors related to RA fatigue.
7. Belza B, Dewing K. Fatigue. In: Bartlett S, editor. Clinical care in the rheumatic diseases. 3rd ed. Atlanta: Association of Rheumatology Health Professions; 2006. p. 285–8.
8. • Minnock P, Ringnér A, Bresnihan B, Veale D, FitzGerald O, McKee G. Perceptions of the cause, impact, and management of presistent fatigue in patients with rheumatoid arthritis following tumour necrosing actor inhibition therapy. Musculoskeletal Care. 2016 [epub ahead of print]. Provides a good overview of the patient’s perspective on fatigue.
9. • van Tuyl L, Sadlonova M, Hewlett S, Davis B, Flurey C, Goel N, et al. The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-peceived remission. Ann Rheum Dis. 2016 [epub ahead of print 2016 Nov 30]. Multi-country data on patient perspectives on RA remission, including the role of fatigue.
10. Felson D, Smolen J, Wells G, Zhang B, van Tuyl L, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthrits Rheum. 2011;63:573–86.
11. Strand V, Wright G, Bergman M, Tambiah J, Taylor P. Patient expectations and perceptions of goal-setting strategies for disease management in rheumatoid arthritis. J Rheumatol. 2015;42:2046–54.
12. •• Ward M, Guthrie L, Dasgupta A. Direct and indirect determinants of the patient global assessment in rheumatoid arthritis: differences by level of disease activity. Arthritis Care Res. 2016 [epub ahead of print 2016 Jun 6]. Important information on the determinants of patient global assessments, which are used to determine treatment response.
13. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum. 2008;59(10):1371–7.
14. Hewlett S, Hehir M, Kirwan JR. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Rheum. 2007;57(3):429–39.
15. Hewlett S, Dures E, Almeida C. Measures of fatigue. Arthritis Care Res. 2011;63(11 Suppl):S263–S86.
16. PROMIS Measure development and research [Available from: http://www.healthmeasures.net/explore-measurement-systems/promis/measure-development-research.
17. Bartlett S, Orbai A, Duncan T, DeLeon E, Ruffing V, Clegg-Smith K, et al. Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis. PLoS One. 2015;10:e0138543.
18. Katz P, Pedro S, Michaud K. Performance of the PROMIS 29-item profile in rheumatoid arthritis, osteoarthritis, fibromyalgia, and systemic lupus erythematosus. Arthritis Care Res. epub ahead of print, 2016.
19. Hegarty R, Conner T, Stebbings S, Treharne G. Feel the fatigue and be active anyway: physical activity on high-fatigue days protects adults with arthritis from decrements in same-day positive mood. Arthritis Care Res. 2015;67:1230–6.
20. Surowiec I, Gjesdal C, Jonsson G, Norheim K, Lundstedt T, Trygg J, et al. Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment. Rheumatol Int. 2016;36:703–11.
21. • van Steenbergen H, Tsonaka R, Huizinga T, Boonen A, van der Helm-van Mil A. Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study. RMD Open. 2015;4:e000041. Longitudinal study of RA fatigue over 8 years of follow-up.
22. Castrejon I, Nikiphorou E, Jain R, Huang A, Block J, Pincus T. Assessment of fatigue in routine care on a Multidimensional Health Assessment Questionnaire [MDHAQ]: a cross-sectional study of associations with RAPID3 and other variables in different rheumatic diseases. Clin Exp Rheumatol. 2016;34:901–9.
23. Lee Y, Frits M, Iannaccone C, Weinblatt M, Shadick N, Williams D, et al. Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors. Arthritis Rheum. 2014;66:2006–14.
24. • Olsen C, Lie E, Kvien T, Zangi H. Predictors of fatigue in rheumatoid arthritis patients in remission or in low disease activity state. Arthritis Care Res. 2016;68:1043–8. Longitudinal study of fatigue after reaching low disease activity or remission.
25. Camacho E, Verstappen S, Chipping J, Symmons D. Learned helplessness predicts functional disability, pain, and fatigue in patients with recent-onset inflammatory polyarthritis. Rheumatology. 2013;52:1233–8.
26. Druce K, Jones G, Macfarlane G, Verstappen S, Basu N. The longitudinal course of fatigue in rheumatoid arthritis: results from the Norfolk Arthritis Register. J Rheumatol. 2015;42:2059–65.
27. Putrik P, Ramiro S, Hifinger M, Keszei A, Hmamouchi I, Dougados M, et al. In wealthier countries, patients perceive worse impact of the disease, although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study. Ann Rheum Dis. 2016;75:715–20.
28. Nicklin J, Cramp F, Kirwan J, Greenwood R, Urban M, Hewlett S. Measuring fatigue in RA: a cross-sectional study to evaluate the Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire, Visual Analog Scales, and Numerical Rating Scales. Arthritis Care & Research. 2010;62:1559–68.
29. Feldthusen C, Grimby-Ekman A, Florsblad-d’Ella H, Jacobsson L, Mannerkorpi K. Explanatory factors and predictors of fatigue in persons with rheumatoid arthritis: a longitudinal study. J Rehabil Med. 2016;48:469–76.
30. Feldthusen C, Dean E, Forsblad-d’Elia H, Mannerkorpi K. Effects of person-centered physical therapy on fatigue-related variables in persons with rheumatoid arthritis: a randomized controlled trial. Arch Phys Med Rehabil. 2016;97:26–36.
31. Van Hoogmoed D, Fransen J, Bleijenberg G, van Piel P. How to assess fatigue in rheumatoid arthritis: validity and reliability of the Checklist Individual Strength. Arthritis Rheum. 2008;58(Suppl):S868.
32. Vercoulen J, Swanink C, Fennis J, Galama J, van der Meer J, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38:383–92.
33. • van Dartel S, Repping-Wuts J, van Hoogmoed D, Bleijenberg G, van Riel P, Fransen J. Association between fatigue and pain in rheumatoid arthritis: does pain precede fatigue or does fatigue precede pain? Arthritis Care Res. 2013;65:862–9. Longitudinal study examining the time-ordering of pain and fatigue.
34. Rongen-van Dartel S, Repping-Wuts J, van Hoogmoed D, Knoop H, Bleijenberg G, van Riel P, et al. Relationship between objectively assessed physical activity and fatigue in patients with rheumatoid arthritis: inverse correlation of activity and fatigue. Arthritis Care Res. 2014;66:852–60.
35. Rongen-van Dartel S, Repping-Wuts H, Donders R, van Hoogmoed D, Knoop H, Bleijenberg G, et al. A multidimensional “path analysis” model of factors explaining fatigue in rheumatoid arthritis. Clin Exp Rheumatol. 2016;34:200–6.
36. Hann DM, Denniston MM, Baker F. Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res. 2000;9(7):847–54.
37. •• Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E. Role of sleep disturbance, depression, obesity, and physical inactivity in fatigue in rheumatoid arthritis. Arthritis Care & Research. 2016;68:81–90. Included the broadest range of potential predictors of RA fatigue of any study to date.
38. Krupp L, LaRocca N, Muir-Nash J, Steinberg A. The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–3.
39. Durcan L, Wilson F, Cunnane G. The effect of exercise on sleep and fatigue in rheumatoid arthritis: a randomized controlled study. J Rheumatol. 2014;41:1966–73.
40. Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32:811–9.
41. Singh H, Arya S, Talapatra P, Lather K, Mathur R, Singhania A, et al. Assessment of fatigue in rheumatoid arthritis [by Functional Assessment of Chronic Illness Therapy-Fatigue score] and its relation to disease activity and anemia. J Clin Rheumatol. 2014;20:87–90.
42. Smolen J, Kremer J, Gaich C, DeLozier A, Schlichting D, Xie L, et al. Patient-reported outcomes from a randomised phae III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents [RA-BEACON]. Ann Rheum Dis. 2016 [epub ahead of print].
43. Belza BL. Comparison of self-reported fatigue in rheumatoid arthritis and controls. J Rheumatol. 1995;22(4):639–43.
44. Nicassio P, Ormseth S, Custodio M, Irwin M, Olmstead R, Weisman M. A multidimensional model of fatigue in patients with rheumatoid arthritis. J Rheumatol. 2012;39:1807–13.
45. Inanc N, Yilmaz-Oner S, Can M, Sokka T, Direskeneli H. The role of depression, anxiety, fatigue, and fibromyalgia in the evaluation of remission status in patients with rheumatoid arthritis. J Rheumatol. 2014;41:1755–60.
46. Smets E, Garssen B, Cull A, De Haes J. The Multidimensional Fatigue Inventory [MFI]: psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315–25.
47. Løppenthin K, Esbensen B, Østergaard M, Jennum P, Tolver A, Aadahl M, et al. Physical activity and the association with fatigue and sleep in Danish patients with rheumatoid arthritis. Rheumatol Int. 2015;35:1655–64.
48. McNair D, Lorr M, Droppleman L. Profile of mood states manual. New York: Multi-health Systems, Inc; 1992.
49. Minnock P, Veale D, Bresnihan B, FitzGerald O, McKee G. Factors that influence fatigue status in patients with severe rheumatoid arthritis [RA] and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysis. Clin Rheumatol. 2015;34:1857–65.
50. Ware J, Kosinski M, Dewey J. How to score version 2 of the SF-36 ® Health Survey. QualityMetric Incorporated: Lincoln; 2002.
51. •• Druce K, Jones G, Macfarlane G, Basu N. Determining pathways to improvements in fatigue in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Rheum. 2015;67:2303–10. Empirical model of changes in RA fatigue, including both disease- and non-disease-specific factors.
52. • Druce K, Bhattacharya Y, Jones G, Macfarlane G, Basu N. Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology. 2016;55:1786–90. Longitudinal study of RA fatigue following anti-TNF therapy.
53. Druce K, Jones G, Macfarlane G, Basu N. Examining changes in central and peripheral pain as mediates of fatigue improvements: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Care Res. 2016;68:922–6.
54. PROMIS Assessment Center [Available from: https://www.assessmentcenter.net/.
55. Christodoulou C, Junghaenel D, DeWalt D, Rothrock N, Stone A. Cognitive interviewing in the evaluation of fatigue items: results from the patient-reported outcomes measurement information system [PROMIS]. Qual LifeRes. 2008;17:1239–46.
56. Cella D, Lai J, Stone A. Self-reported fatigue: one dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy—Fatigue [FACIT-F] questionnaire. Support Care Cancer. 2011;19:1441–50.
57. Lai J, Cook K, Stone A, Beaumont J, Cella D. Classical test theory and item response theory/Rasch model to assess differences between patient-reported fatigue using 7-day and 4-week recall periods. J Clin Epidemiol. 2009;62:991–7.
58. •• Louati K, Berenbaum F. Fatigue in chronic inflammation—a link to pain pathways. Arthritis Res Ther. 2015;17:254. Review of potential pathways that may lead to fatigue in rheumatic diseases. Strong focus on biological factors.
59. • Matcham F, Ali S, Hotopf M, Chalder T. Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev. 2015;39:16–29. Systematic review of psychological and cognitive factors associated with fatigue in RA.
60. •• Karshidoff B, Sundelin T, Lasselin J. Role of inflammation in human fatigue: relevance of multidimensional assessments and potential neuronal mechanisms. Front Immunol. 2017:8–21. Describes multiple factors that may affect fatigue in inflammatory conditions, including systemic inflammation and specific neuronal processes.
61. Madsen S, Danneskiold-Samsøe B, Stockmarr A, Bartels E. Correlations between fatigue and disease duration, disease activity, and pain in patients with rheumatoid arthritis: a systemaic review. Scand J Rheumatol. 2016;45:255–61.
62. Evers A, Verhoeven E, van Middendorp H, Sweep F, Kraaimaat F, Donders A, et al. Does stress affect the joints? Daily stressors, stress vulnerability, immune and HPA axis activity, and short-term disease and symptom fluctuations in rheumatoid arthritis. Ann Rheum Dis. 2014;73:1683–8.
63. Irwin M, Olmstead R, Carroll J. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80:40–52.
64. Chauffier K, Salliot C, Berenbaum F. J S. Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis. Rheumatology. 2012;51:60–8.
65. Walsh D, McWilliams D. Mechanisms, impact and management of pain in rheumatoid arthritis. Nature Rev Rheumatol. 2014;10:581–92.
66. Grøn K, Ornbjerg L, Heftland M, Aslam F, Khan N, Jacobs J, et al. The association fo fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program. Clin Exp Rheumatol. 2014;32:869–77.
67. Hewlett S, Cockshott Z, Byron M, Kitchen K, Tipler S, Pope D, et al. Patients’ perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum. 2005;53(5):697–702.
68. Sturgeon J, Finan P, Zautra A. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nature Rev Rheumatol. 2016;12:532–42.
69. Haapakoski R, Mathieu J, Ebmeier K, Alenius H, Kivimäki M. Cumulative meta-analysis of interleukines 6 and 1b, tumor crosis factor a and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–15.
70. Miller A, Raison C. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34.
71. Capuron L, Lasselin J, Castanon N. Role of adiposity-driven inflammation in depressive morbidity. Neuropsychophamacol Rev. 2017;42:115–28.
72. Abad VC, Sarinas PS, Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev. 2008;12(3):211–28.
73. Bjurström M, Olmstead R, Irwin M. Reciprocal relationship between sleep macrostructure and evening and morning cellular inflammation in rheumatoid arthritis. Psychosom Med. 2017;79:24–33.
74. Irwin M, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald J, Ranganath V, et al. Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep. 2012;35:537–43.
75. Westhovens R, Van der Elst K, Matthys A, Tran M, Gilloteau I. Sleep problems in patients with rheumatoid arthritis. J Rheumatol. 2014;40:31–40.
76. Løppenthin K, Esbensen B, Jennum P, Østergaard M, Tolver A, Thomsen T, et al. Sleep quality and correlates of poor sleep in patients with rheumatoid arthritis. Clin Rheumatol. 2015;2029–39.
77. Lee Y, Lu B, Edwards R, Wasan A, Nassikas N, Clauw D, et al. The role of sleep problems in central pain processing in rheumatoid arthritis. Arthritis Rheum. 2013;65:59–68.
78. Katz P, Yazdany J, Trupin L, Schmajuk G, Margaretten M, Criswell L, et al. Sex differences in assessment of obesity in rheumatoid arthritis. Arthritis Care & Research. 2013;65:62–70.
79. Mancuso P. The role of adipokines in chronic inflammation. Immunotargets Ther. 2016;5:47–56.
80. Mancuso C, Rincon M, Sayles W, Paget S. Comparison of energy expenditure from lifestyle physical activities between patients with rheumatoid arthritis and healthy controls. Arthritis Rheum (Arthritis Care Res). 2007;57:672–8.
81. Metsios G, Koutedakis Y, Veldhjuijzen van Zanten J, Stavropoulos-Kalinoglou A, Vitalis P, Duda J, et al. Cardiorespiratory fitness levels and their association with cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology. 2015;54:2215–25.
82. Hood V, Granat M, Maxwell D, Hasler J. A new method of using heart rate to represent energy expenditure: the total heart beat index. Arch Phys Med Rehabil. 2002;83:1266–73.
83. Brondel L, Mourey F, Mischis-Troussard C, d’Athis P, Pfitzenmeyer P. Energy cost and cardiorespiratory adaptation in the “get-up-and-go” test in frail elderly women with postural abnormalities and in controls. J Gerontol A Biol Sci Med Sci. 2005;60A:98–103.
84. Edwards M, Loprinzi P. Systemic inflammation as a function of the individual and combined associations of sedentary behaviour, physical activity and cardiorespiratory fitness. Clin Physiol Funct Imaging. 2016 [epub ahead of print].
85. Kramer H, Fontaine K, Bathon J, Giles J. Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum. 2012;64:2438–50.
86. Baker J, Long J, Ibrahim S, Leonard M, Katz P. Men are at greater risk of lean mass deficits in rheumatoid arthritis. Arthritis Care Res. 2015;67:112–9.
87. Engvall IL, Elkan AC, Tengstrand B, Cederholm T, Brismar K, Hafstrom I. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor. Scand J Rheumatol. 2008;37(5):321–8.
88. Giles J, Bartlett S, Andersen R, Thompson R, Fontaine K, Bathon J. Association of body fat with C-reactive protein in rheumatoid arthrits. Arthritis Rheum. 2008;58:2632–41.
89. Powers S, Lynch G, Murphy K, Reid M, Zijdewind I. Disease-induced skeletal muscle atrophy and fatigue. Med Sci Sports Exerc. 2016;48:2307–19.
90. •• Morris G, Berk M, Galecki P, Walder K, Maes M. The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Mol Neurobiol. 2016;53:1195–219. Review of pathways that may underlie fatigue in autoimmune and inflammatory conditions, with a focus on biological factors.
91. •• Almeida C, Choy E, Hewlett S, Kirwan J, Cramp F, Chalder T, et al. Biologic interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev. 2016 [6]. Systematic review of the impact of biologic therapy on RA fatigue.
92. •• Cramp F, Hewlett S, Almeida C, Kirwan K, Choy E, Chalder T, et al. Non-pharmacological interventions for RA fatigue. Cochrane Database Syst Rev. 2013 [8]:CD008322. Systematic review of interventions for RA fatigue.
93. •• Rongen-van Dartel S, Repping-Wuts H, Flendrie M, Bleijenberg G, Metsios G, van den Hout W, et al. Effect of aerobic exercise training on fatigue in rheumatoid arthritis: a meta-analysis. Arthritis Care Res. 2015;67:1054–62. Systematic review of exercise interventions on RA fatigue.
94. Katz P, Margaretten M, Gergorich S, Kaplan S, Rush S, Trupin L. A randomized controlled trial for a physical activity intervention for RA fatigue. American College of Rheumatology; San Francisco, CA: Arthritis Rheum; 2015. p. abstract 2083.
95. Dures E, Kitchen K, Almeida C, Ambler N, Cliss A, Hammond A, et al. “They didn’t tell us, they made us work it out ourselves”: patient perspectivies of a cognitive-behavioral program for rheumatoid arthritis fatigue. Arthritis Care Res. 2012;64:494–501.
96. Repping-Wuts H, van Riel P, van Achterberg T. Rheumatologists’ knowledge, attitude and current management of fatigue in patients with rheumatoid arthritis [RA]. Clin Rheumatol. 2008.